Report
Eric Le Berrigaud

ROCHE: Acquisition of Spark Therapeutics | BUY - Top Picks | CHF315

ROCHE - BUY - Top Picks | CHF315(+14%)
Acquisition of Spark Therapeutics

Increased presence in gene therapy
Roche reinforces its presence in haemophilia
The race with its neighbour has started
Underlyings
Roche Holding AG

Roche Holding AG ADS

Provider
Bryan Garnier
Bryan Garnier

Since 1996, Bryan, Garnier & Co has been growing with an absolute conviction that the investment banking landscape would experience a major revolution: most of the large local generalist banking groups will disappear to the benefit of a handful of global powerhouses, and an emerging group of independent, highly specialised boutique investment banks.

Analysts
Eric Le Berrigaud

Other Reports on these Companies
Other Reports from Bryan Garnier

ResearchPool Subscriptions

Get the most out of your insights

Get in touch